HealthEquity (NASDAQ:HQY) Given New $110.00 Price Target at BTIG Research

HealthEquity (NASDAQ:HQY) had its target price dropped by investment analysts at BTIG Research from $130.00 to $110.00 in a research note issued to investors on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. BTIG Research’s price objective indicates a potential upside of 48.89% from the company’s current price.

Several other research analysts have also commented on HQY. Citigroup reissued an “outperform” rating on shares of HealthEquity in a research note on Thursday, December 4th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a $120.00 price target on shares of HealthEquity in a research report on Friday, December 5th. KeyCorp upped their price objective on HealthEquity from $120.00 to $125.00 and gave the stock an “overweight” rating in a research report on Thursday, January 8th. BMO Capital Markets reiterated a “market perform” rating on shares of HealthEquity in a report on Thursday, December 4th. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of HealthEquity in a report on Thursday, January 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, twelve have given a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $116.93.

HealthEquity Trading Up 0.9%

HQY opened at $73.88 on Tuesday. HealthEquity has a 52 week low of $72.90 and a 52 week high of $116.65. The business has a fifty day simple moving average of $88.03 and a 200-day simple moving average of $92.07. The firm has a market cap of $6.31 billion, a P/E ratio of 33.89, a P/E/G ratio of 0.92 and a beta of 0.24. The company has a quick ratio of 4.13, a current ratio of 4.13 and a debt-to-equity ratio of 0.46.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings data on Wednesday, December 3rd. The company reported $1.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.11. HealthEquity had a return on equity of 12.94% and a net margin of 14.86%.The firm had revenue of $322.16 million for the quarter, compared to the consensus estimate of $320.92 million. During the same quarter in the previous year, the business earned $0.78 EPS. The company’s quarterly revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. On average, equities analysts expect that HealthEquity will post 2.32 earnings per share for the current year.

Insider Transactions at HealthEquity

In other news, EVP Elimelech Rosner sold 10,959 shares of the firm’s stock in a transaction dated Thursday, December 18th. The stock was sold at an average price of $95.45, for a total transaction of $1,046,036.55. Following the sale, the executive vice president owned 45,742 shares of the company’s stock, valued at approximately $4,366,073.90. This trade represents a 19.33% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Delano Ladd sold 1,500 shares of the firm’s stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $94.72, for a total transaction of $142,080.00. Following the sale, the executive vice president directly owned 73,979 shares in the company, valued at approximately $7,007,290.88. The trade was a 1.99% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 13,959 shares of company stock valued at $1,344,957 over the last ninety days. 1.50% of the stock is owned by company insiders.

Institutional Trading of HealthEquity

Institutional investors and hedge funds have recently made changes to their positions in the company. Graham Capital Management L.P. grew its stake in HealthEquity by 33.3% during the 4th quarter. Graham Capital Management L.P. now owns 14,556 shares of the company’s stock worth $1,333,000 after buying an additional 3,638 shares during the last quarter. Magnetar Financial LLC acquired a new stake in shares of HealthEquity in the fourth quarter valued at approximately $3,025,000. Beacon Investment Advisors LLC grew its position in shares of HealthEquity by 15.2% during the fourth quarter. Beacon Investment Advisors LLC now owns 31,526 shares of the company’s stock worth $2,888,000 after acquiring an additional 4,160 shares during the last quarter. Aster Capital Management DIFC Ltd acquired a new position in shares of HealthEquity in the 4th quarter valued at $28,000. Finally, Vanguard Personalized Indexing Management LLC increased its holdings in shares of HealthEquity by 7.8% in the 4th quarter. Vanguard Personalized Indexing Management LLC now owns 11,582 shares of the company’s stock valued at $1,061,000 after acquiring an additional 840 shares during the period. 99.55% of the stock is owned by hedge funds and other institutional investors.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.